Research Scholars Program - Gilead Sciences
Forecasted
Gilead Sciences' Research Scholars Program funds innovative research by emerging investigators in HIV, viral hepatitis, primary biliary cholangitis, and oncology, with a focus on diversity and scientific advancement.
Funder: Gilead Sciences
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Typically $180,000 USD over 2 years (paid in annual installments to the institution; may vary by country/region).
Summary: Supports innovative research by emerging investigators in key therapeutic areas, with an emphasis on diversity and advancing scientific discovery.
Key Information: This is a forecasted opportunity; deadlines and details may shift—check the program page for updates.
Description
The Research Scholars Program from Gilead Sciences is designed to empower emerging investigators worldwide by providing targeted funding for innovative research projects. The program aims to amplify diverse voices and support unique approaches that address knowledge gaps and unmet medical needs, particularly in therapeutic areas such as HIV, viral hepatitis, primary biliary cholangitis, and oncology (solid tumors). With a strong commitment to inclusivity, the program also seeks to reduce barriers for underrepresented groups in research, ultimately advancing health equity and scientific progress.
